Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 3428253, 13 pages
https://doi.org/10.1155/2017/3428253
Review Article

Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials

1Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China
2Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
3Department of Traditional Chinese Medicine, Medical College of Xiamen University, Xiamen 361005, China

Correspondence should be addressed to Xiaorong Chen; moc.361@nehc3gnoroaix and Yongchun Yu; moc.361@88nuhcgnoyeuy

Received 31 January 2017; Accepted 4 April 2017; Published 7 June 2017

Academic Editor: Senthami R. Selvan

Copyright © 2017 Zongguo Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Yau-Tuen Chan, Wei Guo, Yibin Feng, Ning Wang, Hor-Yue Tan, and Sha Li, “Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensia Benth. and its active ingredient protocatechualdehyde,” Oncotarget, vol. 8, no. 62, pp. 105848–105859, 2017. View at Publisher · View at Google Scholar
  • Yi-Hong Wu, Hsing-Yu Chen, Chyong-Huey Lai, Chein-Shuo Yeh, Jong-Hwei S. Pang, Jian-Tai Qiu, Hung-Hsueh Chou, Lan-Yan Yang, and Yu-Bin Pan, “Use of Chinese Herbal Medicine Improves Chemotherapy-Induced Thrombocytopenia among Gynecological Cancer Patients: An Observational Study,” Evidence-Based Complementary and Alternative Medicine, vol. 2018, pp. 1–8, 2018. View at Publisher · View at Google Scholar
  • Ying Zhang, Hiroko Kishi, and Sei Kobayashi, “Add-on Therapy with Traditional Chinese Medicine: An Efficacious Approach for Lipid Metabolism Disorders,” Pharmacological Research, 2018. View at Publisher · View at Google Scholar
  • Lingling Sun, Paul Fahey, Xiaoshu Zhu, Weng Ng, Zhuo Ping Chen, Yiwen Qiu, Hezheng Lai, Jietao Lin, and Lizhu Lin, “A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China,” Integrative Cancer Therapies, pp. 153473541877581, 2018. View at Publisher · View at Google Scholar
  • Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu, and Ram I. Mahato, “Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapy,” Materials Today, 2018. View at Publisher · View at Google Scholar
  • Lin-Yen Kuan, Wei-Shu Wang, Fei-Ting Hsu, Kai-Lee Wang, Wen-Chang Chen, Yu-Chang Liu, Wei-Lung Chen, Jiann-Hwa Chen, Tsu-Te Liu, and Wei-Ting Chen, “Magnolol induces apoptosis and inhibits ERK-modulated metastatic potential in hepatocellular carcinoma cells,” In Vivo, vol. 32, no. 6, pp. 1361–1368, 2018. View at Publisher · View at Google Scholar
  • Feiyu Chen, Ning Wang, and Yibin Feng, “What Chinese Medicine Can Do for Liver Cancer?,” Liver Cancer, 2018. View at Publisher · View at Google Scholar
  • Axel Haferkamp, Felix K.-H. Chun, Eva Juengel, Holger H.H. Erb, Jochen Rutz, and Roman A. Blaheta, “Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors,” Cancer Letters, vol. 435, pp. 121–126, 2018. View at Publisher · View at Google Scholar
  • Pengfei Yuan, Jinyu Li, Adila Aipire, Yi Yang, Lijie Xia, Jinyao Li, Xinhui Wang, and Yijie Li, “Cistanche tubulosa phenylethanoid glycosides induce apoptosis in H22 hepatocellular carcinoma cells through both extrinsic and intrinsic signaling pathways 06 Biological Sciences 0601 Biochemistry and Cell Biology,” BMC Complementary and Alternative Medicine, vol. 18, no. 1, 2018. View at Publisher · View at Google Scholar
  • Jing-Hao Zhang, Chao Zheng, Xiao-Jun Zhu, Xin Zhang, Zhi-Jun Hou, Zhen-Hua Zhou, Yu-Qing Wang, Kai-Xia Wang, Zhuo Yu, Man Li, Yue-Qiu Gao, and Xue-Hua Sun, “Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled Trial,” Evidence-Based Complementary and Alternative Medicine, vol. 2019, pp. 1–6, 2019. View at Publisher · View at Google Scholar
  • Chongyang Ma, Tian Xu, Xiaoguang Sun, Shuang Zhang, Shuling Liu, Shuning Fan, Chaofang Lei, Feifei Tang, Changming Zhai, Changxiang Li, Juan Luo, Qingguo Wang, Wei Wei, Xueqian Wang, and Fafeng Cheng, “Network Pharmacology and Bioinformatics Approach Reveals the Therapeutic Mechanism of Action of Baicalein in Hepatocellular Carcinoma,” Evidence-Based Complementary and Alternative Medicine, vol. 2019, pp. 1–15, 2019. View at Publisher · View at Google Scholar